Aia Group LTD Boston Scientific Corp Transaction History

Aia Group LTD

$3.86 Billion
Q4 2024

A detailed history of Aia Group LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Aia Group LTD holds 96,312 shares of BSX stock, worth $9.7 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

96,312

Previous 4,444 2067.24%

Holding current value

$9.7 Million

Previous $372,000 2212.37%

% of portfolio

0.22%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$83.62 - $91.5 $7.68 Million - $8.41 Million	91,868 Added 2067.24%	96,312 $8.6 Million
Q3 2024 Oct 31, 2024	SELL	$72.96 - $84.0 $50,123 - $57,708	-687 Reduced 13.39%	4,444 $372,000
Q2 2024 Jul 31, 2024	SELL	$67.33 - $77.71 $72,447 - $83,615	-1,076 Reduced 17.34%	5,131 $395,000
Q1 2024 May 06, 2024	SELL	$57.6 - $68.62 $927,936 - $1.11 Million	-16,110 Reduced 72.19%	6,207 $425,000
Q4 2023 Jan 31, 2024	BUY	$48.64 - $57.81 $503,229 - $598,102	10,346 Added 86.43%	22,317 $1.29 Million
Q3 2023 Nov 01, 2023	BUY	$50.19 - $54.68 $109,113 - $118,874	2,174 Added 22.19%	11,971 $632,000
Q2 2023 Jul 28, 2023	SELL	$49.72 - $54.64 $117,637 - $129,278	-2,366 Reduced 19.45%	9,797 $529,000
Q1 2023 Apr 28, 2023	BUY	$45.09 - $50.03 $548,429 - $608,514	12,163 New	12,163 $608,000
Q2 2022 Aug 11, 2022	SELL	$35.24 - $47.1 $89,298 - $119,351	-2,534 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$40.9 - $45.1 $1.65 Million - $1.82 Million	-40,456 Reduced 94.11%	2,534 $112,000
Q4 2021 Feb 11, 2022	BUY	$38.07 - $44.87 $1.64 Million - $1.93 Million	42,990 New	42,990 $1.83 Million

Others Institutions Holding BSX

# of Institutions

1,669

Shares Held

1.22B

Call Options Held

8.76M

Put Options Held

9.42M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $144B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.

Account